In contrast, the upregulation of the PKM2/PKM1 ratio via the LncRNA XIST/miR-137 axis was found to increase glycolysis and chemotherapy tolerance in colorectal cancer (91, 92). The gene discussed is PKM; the disease is colorectal cancer.